Fitzpatrick Institute for Photonics Fitzpatrick Institute for Photonics
Pratt School of Engineering
Duke University

 HOME > pratt > FIP    Search Help Login pdf version printable version 

Publications of Ganesan Vaidyanathan    :chronological  alphabetical  combined  bibtex listing:

Papers Published

  1. G Vaidyanathan, Virus hunters: catching bugs in the field., Cell, vol. 147 no. 6 (December, 2011), pp. 1209-11, ISSN 1097-4172 [doi]  [abs]
  2. BB Chin, A Hjelemand, J Rich, H Song, C Lascola, R Storms, R McLendon, R Reiman, KL Greer, SD Metzler, D Macdougald, D Dai, G Vaidyanathan, Synthesis and preliminary evaluation of n.c.a. iodoquine: A novel radiotracer with high uptake in cells with high ALDH1 expression., Current radiopharmaceuticals (October, 2011), ISSN 1874-4729  [abs]
  3. G Vaidyanathan, Dam controversy: Remaking the Mekong., Nature, vol. 478 no. 7369 (October, 2011), pp. 305-7, ISSN 1476-4687 [doi]
  4. G Vaidyanathan, D McDougald, L Grasfeder, MR Zalutsky, B Chin, An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine., Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, vol. 69 no. 10 (October, 2011), pp. 1401-6, ISSN 1872-9800 [doi]  [abs]
  5. G Vaidyanathan, MR Zalutsky, Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy., Current radiopharmaceuticals, vol. 4 no. 4 (October, 2011), pp. 283-94, ISSN 1874-4729  [abs]
  6. G Vaidyanathan, Apes in Africa: The cultured chimpanzees., Nature, vol. 476 no. 7360 (August, 2011), pp. 266-9, ISSN 1476-4687 [doi]
  7. G Vaidyanathan, N Ngamphaiboon, FJ Hernandez-Ilizaliturri, Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: case series and a review of the literature., Annals of hematology, vol. 90 no. 8 (August, 2011), pp. 955-62, ISSN 1432-0584 [doi]  [abs]
  8. V Irikefe, G Vaidyanathan, L Nordling, A Twahirwa, E Nakkazi, R Monastersky, Science in Africa: The view from the front line., Nature, vol. 474 no. 7353 (June, 2011), pp. 556-9, ISSN 1476-4687 [doi]
  9. G Vaidyanathan, Science in Africa: The wheat stalker., Nature, vol. 474 no. 7353 (June, 2011), pp. 563-5, ISSN 1476-4687 [doi]
  10. G Vaidyanathan, B White, DJ Affleck, D McDougald, MR Zalutsky, Radioiodinated O(6)-Benzylguanine derivatives containing an azido function., Nuclear medicine and biology, vol. 38 no. 1 (January, 2011), pp. 77-92, ISSN 1872-9614 [doi]  [abs]
  11. M Hens, G Vaidyanathan, XG Zhao, DD Bigner, MR Zalutsky, Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands., Nuclear medicine and biology, vol. 37 no. 7 (October, 2010), pp. 741-50, ISSN 1872-9614 [doi]  [abs]
  12. Y Kato, G Vaidyanathan, MK Kaneko, K Mishima, N Srivastava, V Chandramohan, C Pegram, ST Keir, CT Kuan, DD Bigner, MR Zalutsky, Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas., Nuclear medicine and biology, vol. 37 no. 7 (October, 2010), pp. 785-94, ISSN 1872-9614 [doi]  [abs]
  13. G Vaidyanathan, MG Fakih, A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver., Anticancer research, vol. 30 no. 2 (February, 2010), pp. 677-9, ISSN 1791-7530  [abs]
  14. G Vaidyanathan, DJ Affleck, XG Zhao, ST Keir, MR Zalutsky, [Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma., Current radiopharmaceuticals, vol. 3 no. 1 (2010), pp. 29-36, ISSN 1874-4729 [doi]  [abs]
  15. G Vaidyanathan, A Groman, G Wilding, MG Fakih, Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer., Oncology, vol. 79 no. 1-2 (2010), pp. 67-71, ISSN 1423-0232 [doi]  [abs]
  16. G Vaidyanathan, H Song, D Affleck, DL McDougald, RW Storms, MR Zalutsky, BB Chin, Targeting aldehyde dehydrogenase: a potential approach for cell labeling., Nuclear medicine and biology, vol. 36 no. 8 (November, 2009), pp. 919-29, ISSN 1872-9614 [doi]  [abs]
  17. G Vaidyanathan, E Jestin, T Olafsen, AM Wu, MR Zalutsky, Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK., Nuclear medicine and biology, vol. 36 no. 6 (August, 2009), pp. 671-80, ISSN 1872-9614 [doi]  [abs]
  18. M Hens, G Vaidyanathan, P Welsh, MR Zalutsky, Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands., Nuclear medicine and biology, England, vol. 36 no. 2 (February, 2009), pp. 117-28, ISSN 0969-8051  [abs]
  19. G Vaidyanathan, BJ White, MR Zalutsky, Propargyl 4-[F]fluorobenzoate: A Putatively More Stable Prosthetic group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry., Current radiopharmaceuticals, vol. 2 no. 1 (January, 2009), pp. 63-74, ISSN 1874-4729  [abs]
  20. G Vaidyanathan, Meta-iodobenzylguanidine and analogues: chemistry and biology., The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology, vol. 52 no. 4 (December, 2008), pp. 351-68, ISSN 1824-4785  [abs]
  21. K Simmons, J Kinney, A Owens, DA Kleier, K Bloch, D Argentar, A Walsh, G Vaidyanathan, Practical outcomes of applying ensemble machine learning classifiers to High-Throughput Screening (HTS) data analysis and screening., Journal of chemical information and modeling, vol. 48 no. 11 (November, 2008), pp. 2196-206, ISSN 1549-9596 [doi]  [abs]
  22. C Sun, A Dobi, A Mohamed, H Li, RL Thangapazham, B Furusato, S Shaheduzzaman, SH Tan, G Vaidyanathan, E Whitman, DJ Hawksworth, Y Chen, M Nau, V Patel, M Vahey, JS Gutkind, T Sreenath, G Petrovics, IA Sesterhenn, DG McLeod, S Srivastava, TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation., Oncogene, vol. 27 no. 40 (September, 2008), pp. 5348-53, ISSN 1476-5594 [doi]  [abs]
  23. AA Rosenkranz, G Vaidyanathan, OR Pozzi, VG Lunin, MR Zalutsky, AS Sobolev, Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At., International journal of radiation oncology, biology, physics, vol. 72 no. 1 (September, 2008), pp. 193-200, ISSN 0360-3016 [doi]  [abs]
  24. G Vaidyanathan, MR Zalutsky, Astatine Radiopharmaceuticals: Prospects and Problems., Current radiopharmaceuticals, vol. 1 no. 3 (September, 2008), pp. 177, ISSN 1874-4729  [abs]
  25. K Simmons, J Kinney, A Owens, D Kleier, K Bloch, D Argentar, A Walsh, G Vaidyanathan, Comparative study of machine-learning and chemometric tools for analysis of in-vivo high-throughput screening data., Journal of chemical information and modeling, vol. 48 no. 8 (August, 2008), pp. 1663-8, ISSN 1549-9596 [doi]  [abs]
  26. G Vaidyanathan, DJ Affleck, J Norman, S O'Dorisio, MR Zalutsky, A radioiodinated MIBG-octreotate conjugate exhibiting enhanced uptake and retention in SSTR2-expressing tumor cells., Bioconjugate chemistry, vol. 18 no. 6 (November, 2007), pp. 2122-30, ISSN 1043-1802 [doi]  [abs]
  27. MR Zalutsky, DA Reardon, OR Pozzi, G Vaidyanathan, DD Bigner, Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies., Nuclear medicine and biology, vol. 34 no. 7 (October, 2007), pp. 779-85, ISSN 0969-8051 [doi]  [abs]
  28. G Vaidyanathan, DJ Affleck, KL Alston, XG Zhao, M Hens, DH Hunter, J Babich, MR Zalutsky, A kit method for the high level synthesis of [211At]MABG., Bioorganic & medicinal chemistry, vol. 15 no. 10 (May, 2007), pp. 3430-6, ISSN 0968-0896 [doi]  [abs]
  29. J Park, G Vaidyanathan, B Singh, RS Gupta, Identification and biochemical studies on novel non-nucleoside inhibitors of the enzyme adenosine kinase., The protein journal, vol. 26 no. 3 (April, 2007), pp. 203-12, ISSN 1572-3887 [doi]  [abs]
  30. G Vaidyanathan, MR Zalutsky, Synthesis of N-succinimidyl 4-guanidinomethyl-3-[*I]iodobenzoate: a radio-iodination agent for labeling internalizing proteins and peptides., Nature protocols, vol. 2 no. 2 (2007), pp. 282-6, ISSN 1750-2799 [doi]  [abs]
  31. G Vaidyanathan, KL Alston, DD Bigner, MR Zalutsky, Nepsilon-(3-[*I]Iodobenzoyl)-Lys5-Nalpha-maleimido-Gly1-GEEEK ([*I]IB-Mal-D-GEEEK): a radioiodinated prosthetic group containing negatively charged D-glutamates for labeling internalizing monoclonal antibodies., Bioconjugate chemistry, vol. 17 no. 4 (December, 2006), pp. 1085-92, ISSN 1043-1802 [doi]  [abs]
  32. G Vaidyanathan, DJ Affleck, M Schottelius, H Wester, HS Friedman, MR Zalutsky, Synthesis and evaluation of glycosylated octreotate analogues labeled with radioiodine and 211At via a tin precursor., Bioconjugate chemistry, vol. 17 no. 1 (September, 2006), pp. 195-203, ISSN 1043-1802 [doi]  [abs]
  33. S Shankar, MR Zalutsky, H Friedman, G Vaidyanathan, Molecular imaging of alkylguanine-DNA alkyltransferase: further evaluation of radioiodinated derivatives of O6-benzylguanine., Nuclear medicine and biology, vol. 33 no. 3 (April, 2006), pp. 399-407, ISSN 0969-8051 [doi]  [abs]
  34. S Shankar, G Vaidyanathan, CT Kuan, DD Bigner, MR Zalutsky, Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance., Nuclear medicine and biology, vol. 33 no. 1 (January, 2006), pp. 101-10, ISSN 0969-8051 [doi]  [abs]
  35. G Vaidyanathan, MR Zalutsky, Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins., Nature protocols, vol. 1 no. 2 (2006), pp. 707-13, ISSN 1750-2799 [doi]  [abs]
  36. G Vaidyanathan, MR Zalutsky, Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F., Nature protocols, vol. 1 no. 4 (2006), pp. 1655-61, ISSN 1750-2799 [doi]  [abs]
  37. S Shankar, MR Zalutsky, G Vaidyanathan, O6-3-[125I]iodobenzyl-2'-deoxyguanosine ([125I]IBdG): synthesis and evaluation of its usefulness as an agent for quantification of alkylguanine-DNA alkyltransferase (AGT)., Bioorganic & medicinal chemistry, vol. 13 no. 12 (June, 2005), pp. 3889-98, ISSN 0968-0896 [doi]  [abs]
  38. G Vaidyanathan, DJ Affleck, MR Zalutsky, No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue., Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, vol. 62 no. 3 (March, 2005), pp. 435-40, ISSN 0969-8043 [doi]  [abs]
  39. G Vaidyanathan, A Boskovitz, S Shankar, MR Zalutsky, Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: potential peptide radiotherapeutics for somatostatin receptor-positive cancers., Peptides, vol. 25 no. 12 (December, 2004), pp. 2087-97, ISSN 0196-9781 [doi]  [abs]
  40. G Vaidyanathan, DJ Affleck, J Norman, P Welsh, W Liu, SP Johnson, HS Friedman, MR Zalutsky, O6-3-[131I]iodobenzylguanine: improved synthesis and further evaluation of a potential agent for imaging of alkylguanine-DNA alkyltransferase., Bioconjugate chemistry, vol. 15 no. 2 (November, 2004), pp. 402-8, ISSN 1043-1802 [doi]  [abs]
  41. G Vaidyanathan, PC Welsh, KC Vitorello, S Snyder, HS Friedman, MR Zalutsky, A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells., European journal of nuclear medicine and molecular imaging, vol. 31 no. 10 (October, 2004), pp. 1362-70, ISSN 1619-7070 [doi]  [abs]
  42. S Shankar, G Vaidyanathan, DJ Affleck, K Peixoto, DD Bigner, MR Zalutsky, Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent., Nuclear medicine and biology, vol. 31 no. 7 (October, 2004), pp. 909-19, ISSN 0969-8051 [doi]  [abs]
  43. YR Kumar, G Ramulu, VV Vevakanand, G Vaidyanathan, K Srinivas, MK Kumar, K Mukkanti, MS Reddy, S Venkatraman, MV Suryanarayana, A validated chiral HPLC method for the enantiomeric separation of tolterodine tartarate., Journal of pharmaceutical and biomedical analysis, vol. 35 no. 5 (September, 2004), pp. 1279-85, ISSN 0731-7085 [doi]  [abs]
  44. G Vaidyanathan, DJ Affleck, KL Alston, P Welsh, MR Zalutsky, Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells., Nuclear medicine communications, vol. 25 no. 9 (September, 2004), pp. 947-55, ISSN 0143-3636  [abs]
  45. M Boyd, RJ Mairs, WN Keith, SC Ross, P Welsh, G Akabani, J Owens, G Vaidyanathan, R Carruthers, J Dorrens, MR Zalutsky, An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects., The journal of gene medicine, vol. 6 no. 8 (August, 2004), pp. 937-47, ISSN 1099-498X [doi]  [abs]
  46. G Vaidyanathan, MJ Cismowski, G Wang, TS Vincent, KD Brown, SM Lanier, The Ras-related protein AGS1/RASD1 suppresses cell growth., Oncogene, England, vol. 23 no. 34 (July, 2004), pp. 5858-63, ISSN 0950-9232  [abs]
  47. G Vaidyanathan, InfoEvolve: moving from data to knowledge using information theory and genetic algorithms., Annals of the New York Academy of Sciences, United States, vol. 1020 (May, 2004), pp. 227-38, ISSN 0077-8923  [abs]
  48. G Vaidyanathan, S Shankar, DJ Affleck, K Alston, J Norman, P Welsh, H LeGrand, MR Zalutsky, Meta-iodobenzylguanidine derivatives containing a second guanidine moiety., Bioorganic & medicinal chemistry, vol. 12 no. 7 (April, 2004), pp. 1649-56, ISSN 0968-0896 [doi]  [abs]
  49. G Vaidyanathan, MR Zalutsky, Imaging drug resistance with radiolabeled molecules., Current pharmaceutical design, vol. 10 no. 24 (2004), pp. 2965-79, ISSN 1381-6128  [abs]
  50. VV Vivekanand, D Sreenivas Rao, G Vaidyanathan, NM Sekhar, S Avijit Kelkar, P Ramachandra Puranik, A validated LC method for imatinib mesylate., Journal of pharmaceutical and biomedical analysis, England, vol. 33 no. 5 (December, 2003), pp. 879-89, ISSN 0731-7085  [abs]
  51. S Shankar, G Vaidyanathan, D Affleck, PC Welsh, MR Zalutsky, N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs., Bioconjugate chemistry, vol. 14 no. 2 (November, 2003), pp. 331-41, ISSN 1043-1802 [doi]  [abs]
  52. G Vaidyanathan, HS Friedman, DJ Affleck, M Schottelius, HJ Wester, MR Zalutsky, Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts., Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 9 no. 5 (May, 2003), pp. 1868-76, ISSN 1078-0432  [abs]
  53. G Vaidyanathan, DJ Affleck, DD Bigner, MR Zalutsky, N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At., Nuclear medicine and biology, vol. 30 no. 4 (May, 2003), pp. 351-9, ISSN 0969-8051  [abs]
  54. G Vaidyanathan, S Shankar, DJ Affleck, PC Welsh, SK Slade, MR Zalutsky, Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues., Bioconjugate chemistry, vol. 12 no. 5 (February, 2002), pp. 798-806, ISSN 1043-1802  [abs]
  55. G Vaidyanathan, S Shankar, MR Zalutsky, Synthesis of ring- and side-chain-substituted m-iodobenzylguanidine analogues., Bioconjugate chemistry, vol. 12 no. 5 (February, 2002), pp. 786-97, ISSN 1043-1802  [abs]
  56. G Vaidyanathan, DJ Affleck, DD Bigner, MR Zalutsky, Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate., Nuclear medicine and biology, vol. 29 no. 1 (January, 2002), pp. 1-11, ISSN 0969-8051  [abs]
  57. J Dingus, BS Tatum, G Vaidyanathan, JD Hilderbrandt, Purification of G protein beta gamma from bovine brain., Methods in enzymology, United States, vol. 344 (2002), pp. 194-208, ISSN 0076-6879
  58. G Vaidyanathan, DJ Affleck, J Li, P Welsh, MR Zalutsky, A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB)., Bioconjugate chemistry, vol. 12 no. 3 (December, 2001), pp. 428-38, ISSN 1043-1802  [abs]
  59. G Vaidyanathan, DJ Affleck, CM Cavazos, SP Johnson, S Shankar, HS Friedman, MO Colvin, MR Zalutsky, Radiolabeled guanine derivatives for the in vivo mapping of O(6)-alkylguanine-DNA alkyltransferase: 6-(4-[(18)F]Fluoro-benzyloxy)-9H-purin-2-ylamine and 6-(3-[(131)I]Iodo-benzyloxy)-9H-purin-2-ylamine., Bioconjugate chemistry, vol. 11 no. 6 (January, 2001), pp. 868-75, ISSN 1043-1802  [abs]
  60. MR Zalutsky, G Vaidyanathan, Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy., Current pharmaceutical design, vol. 6 no. 14 (September, 2000), pp. 1433-55, ISSN 1381-6128  [abs]
  61. G Vaidyanathan, D Affleck, P Welsh, A Srinivasan, M Schmidt, MR Zalutsky, Radioiodination and astatination of octreotide by conjugation labeling., Nuclear medicine and biology, vol. 27 no. 4 (May, 2000), pp. 329-37, ISSN 0969-8051  [abs]
  62. MA Walicka, G Vaidyanathan, MR Zalutsky, SJ Adelstein, AI Kassis, Survival and DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211., Radiation research, UNITED STATES, vol. 150 no. 3 (September, 1998), pp. 263-8, ISSN 0033-7587  [abs]
  63. G Vaidyanathan, MR Zalutsky, Preparation of 5-[131I]iodo- and 5-[211At]astato-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil by a halodestannylation reaction., Nuclear medicine and biology, ENGLAND, vol. 25 no. 5 (July, 1998), pp. 487-96, ISSN 0969-8051  [abs]
  64. SH Cunningham, RJ Mairs, TE Wheldon, PC Welsh, G Vaidyanathan, MR Zalutsky, Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions., British journal of cancer, SCOTLAND, vol. 77 no. 12 (June, 1998), pp. 2061-8, ISSN 0007-0920  [abs]
  65. TR DeGrado, MR Zalutsky, RE Coleman, G Vaidyanathan, Effects of specific activity on meta-[(131)I]iodobenzylguanidine kinetics in isolated rat heart., Nuclear medicine and biology, ENGLAND, vol. 25 no. 1 (January, 1998), pp. 59-64, ISSN 0969-8051  [abs]
  66. Larsen RH, Vaidyanathan G, Zalutsky MR. The cytotoxicity of a-particle emitting 5-[211AT]Astato-2'-deoxyuridine in human cancer cells. Int J Radiat Biol 1997, 72, 79-90
  67. Cunningham SH, Mairs RJ, Wheldon TE, Welsh PC, Vaidyanathan G, Zalutsky, MR. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions. Brit J Cancer. 1998, 77:2061-2066
  68. Vaidyanathan G, Zalutsky MR. Preparation of 5-[131I]Iodo-([131I]FIAU) and 5-[211At]Astato-1(2-deoxy-2fluro-B-D-arabinoffuranosyl)uracil ([211AT]FAAU) by a halodestannylation reaction. Nucl Med Biol 1998, 25:487-496.
  69. Vaidyanathan, G, Zhao, XG, Larsen RH, Zalutsky MR. 3-[211AT]Astato-4-fluorobenzylguanidine: A potiential therapeutic agent with prolonged retention by neuroblastoma cells. Br J Cancer 1997 76:226-233
  70. Vaidyanathan G, Zalutsky, MR. A new route to guanidines from bromoalkanes. J Org Chem 1997, 62:4867-4869
  71. Vaidyanathan G, Affleck DJ, Zalutsky MR. A method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4[131I]iodobenzoate. Bioconjugate Chem. 1997, 8:724-129
  72. DeGrado TR, Zalutsky MR, Coleman RE, Vaidyanathan G. Effects of specific activity on meta-[131I]iodobenzylguanidine kinetics in isolated rat heart. Nuclear Medicine Biology 1998, 24: 59-64
  73. RH Larsen, G Vaidyanathan, MR Zalutsky, Cytotoxicity of alpha-particle-emitting 5-[211At]astato-2'-deoxyuridine in human cancer cells., International journal of radiation biology, ENGLAND, vol. 72 no. 1 (July, 1997), pp. 79-90, ISSN 0955-3002  [abs]
  74. G Vaidyanathan, MR Zalutsky, Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue., Nuclear medicine and biology, ENGLAND, vol. 24 no. 2 (February, 1997), pp. 171-8, ISSN 0969-8051  [abs]
  75. G Vaidyanathan, XG Zhao, DK Strickland, MR Zalutsky, No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog., Journal of nuclear medicine : official publication, Society of Nuclear Medicine, UNITED STATES, vol. 38 no. 2 (February, 1997), pp. 330-4, ISSN 0161-5505  [abs]
  76. Vaidyanathan G, Affleck DJ, Zalutsky MR. A method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4[131I] iodobenzoate. Bioconjugate Chem. 1997, 8:724-129.
  77. G Vaidyanathan, XG Zhao, RH Larsen, MR Zalutsky, 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells., British journal of cancer, SCOTLAND, vol. 76 no. 2 (1997), pp. 226-33, ISSN 0007-0920  [abs]
  78. G Vaidyanathan, MR Zalutsky, Targeted therapy using alpha emitters., Physics in medicine and biology, ENGLAND, vol. 41 no. 10 (October, 1996), pp. 1915-31, ISSN 0031-9155  [abs]
  79. G Vaidyanathan, HS Friedman, ST Keir, MR Zalutsky, Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model., Nuclear medicine and biology, ENGLAND, vol. 23 no. 6 (August, 1996), pp. 851-6, ISSN 0969-8051  [abs]
  80. G Vaidyanathan, HS Friedman, ST Keir, MR Zalutsky, Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity., British journal of cancer, SCOTLAND, vol. 73 no. 10 (May, 1996), pp. 1171-7, ISSN 0007-0920  [abs]
  81. G Vaidyanathan, RH Larsen, MR Zalutsky, 5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation., Cancer research, UNITED STATES, vol. 56 no. 6 (March, 1996), pp. 1204-9, ISSN 0008-5472  [abs]
  82. Vaidyanathan G, Larsen RH, Zalutsky MR. 5[211at]Astato-2'-deoxyuridine, an a-particle emitting endoradiotherapeutic agent undergoing DNA incorporation. Cancer Res., 1996, 56, 1204-1209.
  83. 2. Vaidyanathan, G., Affleck, D.J. and Zalutsky, M.R. No-carrier-added 4-fluoro-3-[131I]iodobenzylguanidine and 3-[211At]astatao-4-fluorobenzylguanidine. Bioconjugate Chem., 1996, 7: 102-107.
  84. Vaidyanathan, G., Larsen, R.H. and Zalutsky, M.R. 5[211At]Astato-2'-deoxyuridine, an à-particle emitting endoradiotherapeutic agent undergoing DNA incorporation. Cancer Res., 1996, 56, 1204-1209.
  85. 1. Vaidyanathan, G., Larsen, R.H. and Zalutsky, M.R. 5[211At]Astato-2'-deoxyuridine, an à-particle emitting endoradiotherapeutic agent undergoing DNA incorporation. Cancer Res., 1996, 56, 1204-1209.
  86. 3. Vaidyanathan, G., Friedman H.S., Kier, S.T. and Zalutsky, M.R. Localization of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: Effect of specific activity. Brit. J. Cancer, 1996, 73, 1171-1177.
  87. CJ Reist, GE Archer, SN Kurpad, CJ Wikstrand, G Vaidyanathan, MC Willingham, DK Moscatello, AJ Wong, DD Bigner, MR Zalutsky, Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts., Cancer research, UNITED STATES, vol. 55 no. 19 (October, 1995), pp. 4375-82, ISSN 0008-5472  [abs]
  88. G Vaidyanathan, MR Zalutsky, Fluorine-18 labeled chemotactic peptides: a potential approach for the PET imaging of bacterial infection., Nuclear medicine and biology, ENGLAND, vol. 22 no. 6 (August, 1995), pp. 759-64, ISSN 0969-8051  [abs]
  89. G Vaidyanathan, DJ Affleck, MR Zalutsky, Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG., Journal of nuclear medicine : official publication, Society of Nuclear Medicine, UNITED STATES, vol. 36 no. 4 (April, 1995), pp. 644-50, ISSN 0161-5505  [abs]
  90. TR Degrado, MR Zalutsky, G Vaidyanathan, Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart., Nuclear medicine and biology, ENGLAND, vol. 22 no. 1 (January, 1995), pp. 1-12, ISSN 0969-8051  [abs]
  91. EL Johnson, TG Turkington, RJ Jaszczak, DR Gilland, G Vaidyanathan, KL Greer, RE Coleman, MR Zalutsky, Quantitation of 211At in small volumes for evaluation of targeted radiotherapy in animal models., Nuclear medicine and biology, ENGLAND, vol. 22 no. 1 (January, 1995), pp. 45-54, ISSN 0969-8051  [abs]
  92. G Vaidyanathan, MR Zalutsky, No-carrier-added meta-[123I]iodobenzylguanidine: synthesis and preliminary evaluation., Nuclear medicine and biology, ENGLAND, vol. 22 no. 1 (January, 1995), pp. 61-4, ISSN 0969-8051  [abs]
  93. Vaidyanathan, G., Affleck, D.J. and Zalutsky, M.R. Validation of 4-[18F]Fluoro-3-iodobenzylguanidine as a potential PET analog of MIBG. J. Nucl. Med. 1995, 36: 644-650.
  94. Vaidyanathan, G. and Zalutsky, M.R. Fluorine-18 labeled chemotactic peptides: A potential approach for the PET imaging of bacterial infections. Nucl.Med. Biol. 1995, 22:759-764.
  95. 1. Strickland, D.K., Vaidyanathan, G., Friedman, H.S. and Zalutksy, M.R. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines. J. Neurooncol. 1995, 25: 9-17.
  96. Vaidyanathan, G. Affleck DJ, Zalutsky MR. Validation of 4-[18F] Fluoro-3-iodobenzylguanidine as a potential PET analog of MIBG. J Nucl Med 1995, 36:644-650.
  97. 2. Vaidyanathan, G. and Zalutsky, M.R. Fluorine-18 labeled chemotactic peptides: A potential approach for the PET imaging of bacterial infections. Nucl.Med. Biol. 1995, 22:759-764.
  98. 3. Reist, C. J., Archer, G.E., Kurpad, S.N., Wikstrand, C.J., Vaidyanathan, G., Willingham, M.C., Moscatello, D.K., Wong, A.J., Bigner, D.D. and Zalutsky, M.R. Tumor-specific anti-EGFRvIII monoclonal antibodies internalize and localize to tumor xenografts in athymic mice. Cancer Res. 1995, 55: 4375-4382.
  99. RJ Mairs, J Russell, S Cunningham, JA O'Donoghue, MN Gaze, J Owens, G Vaidyanathan, MR Zalutsky, Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma., European journal of cancer (Oxford, England : 1990), ENGLAND, vol. 31A no. 4 (1995), pp. 576-81, ISSN 0959-8049  [abs]
  100. DK Strickland, G Vaidyanathan, HS Friedman, MR Zalutsky, Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines., Journal of neuro-oncology, NETHERLANDS, vol. 25 no. 1 (1995), pp. 9-17, ISSN 0167-594X  [abs]
  101. G Vaidyanathan, DJ Affleck, MR Zalutsky, (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography., Journal of medicinal chemistry, UNITED STATES, vol. 37 no. 21 (October, 1994), pp. 3655-62, ISSN 0022-2623  [abs]
  102. RL Page, PK Garg, G Vaidyanathan, MR Zalutsky, Preclinical evaluation and PET imaging of 18F-labeled Mel-14 F(ab')2 fragment in normal dogs., Nuclear medicine and biology, ENGLAND, vol. 21 no. 7 (October, 1994), pp. 911-9, ISSN 0969-8051  [abs]
  103. DK Strickland, G Vaidyanathan, MR Zalutsky, Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells., Cancer research, UNITED STATES, vol. 54 no. 20 (October, 1994), pp. 5414-9, ISSN 0008-5472  [abs]
  104. G Vaidyanathan, DK Strickland, MR Zalutsky, Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent., International journal of cancer. Journal international du cancer, UNITED STATES, vol. 57 no. 6 (June, 1994), pp. 908-13, ISSN 0020-7136  [abs]
  105. RJ Mairs, MN Gaze, DG Watson, GG Skellern, P Constable, K McKellar, J Owens, G Vaidyanathan, MR Zalutsky, Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine., Nuclear medicine communications, ENGLAND, vol. 15 no. 4 (April, 1994), pp. 268-74, ISSN 0143-3636  [abs]
  106. NS Shepherd, BD Pfrogner, JN Coulby, SL Ackerman, G Vaidyanathan, RH Sauer, TC Balkenhol, N Sternberg, Preparation and screening of an arrayed human genomic library generated with the P1 cloning system., Proceedings of the National Academy of Sciences of the United States of America, UNITED STATES, vol. 91 no. 7 (March, 1994), pp. 2629-33, ISSN 0027-8424  [abs]
  107. G Vaidyanathan, D Affleck, MR Zalutsky, Monoclonal antibody F(ab')2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: in vivo comparison of iodinated and astatinated fragments., Nuclear medicine and biology, ENGLAND, vol. 21 no. 1 (January, 1994), pp. 105-10, ISSN 0969-8051  [abs]
  108. 4. Vaidyanathan G, and Zalutsky MR. Meta-[211 At]Astatobenzylguanidine: Further Evaluation of a Potential Therapeutic Agent. Int. J Cancer. 57:908-913, 1994.
  109. Strickland, D.K., Vaidyanathan, G. and Zalutsky, M.R. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells. Cancer Res. 1994, 54, 5414-5419.
  110. 1. Turkington TG, Zalutsky MR, Jaszczak RJ, Garg PK Vaidyanathan G and Coleman RE. Measuring Astatine-211 Distributions with SPECT. Phys. Med. Biol. 38:1121-1130, 1993.
  111. 2. Vaidyanathan G, Affleck D, and Zalutsky MR. Monoclonal Antibody F(ab')2 Fragment Labeled with N-Succinimidyl 2, 4-Dimethoxy-3Halobenzoates: In Vivo Comparison of Iodinated and Astatinated Fragments. Nucl Med Biol 21:105-110, 1994.
  112. 3. Mairs RJ, Gaze MN, Watson DG, Skellern GG, Constable P, McKellar K, Owens J, Vaidyanathan G, and Zalutsky MR. Synthesis of Carrier-Free 131I-Meta-Iodobenzylguanidine by Novel Routes to Enhance Therapeutic Efficiency. Nucl Med Commun 15:268-274, 1994.
  113. 5. Vaidyanathan G, and Zalutsky MR. An Improved Syntheis of N-Succinimidyl 4-[18 F] Fluorobenzoate and its Application to label an Antibody Fragment. Bioconjugate Chem, 5:352-356, 1994.
  114. MN Gaze, RJ Mairs, G Vaidyanathan, MR Zalutsky, Synthesis of carrier-free 131I-meta-iodobenzyl-guanidine by novel routes to enhance therapeutic efficiency in neuroblastoma., Progress in clinical and biological research, UNITED STATES, vol. 385 (1994), pp. 347-53, ISSN 0361-7742
  115. TG Turkington, MR Zalutsky, RJ Jaszczak, PK Garg, G Vaidyanathan, RE Coleman, Measuring astatine-211 distributions with SPECT., Physics in medicine and biology, ENGLAND, vol. 38 no. 8 (August, 1993), pp. 1121-30, ISSN 0031-9155  [abs]
  116. G Vaidyanathan, MR Zalutsky, No-carrier-added synthesis of meta-[131I]iodobenzylguanidine., Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, ENGLAND, vol. 44 no. 3 (March, 1993), pp. 621-8, ISSN 0969-8043  [abs]
  117. G Vaidyanathan, DD Bigner, MR Zalutsky, Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography., Journal of nuclear medicine : official publication, Society of Nuclear Medicine, UNITED STATES, vol. 33 no. 8 (August, 1992), pp. 1535-41, ISSN 0161-5505  [abs]
  118. G Vaidyanathan, MR Zalutsky, Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate., International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, UNITED STATES, vol. 19 no. 3 (April, 1992), pp. 275-81, ISSN 0883-2897  [abs]
  119. Vaidyanathan, G., Bigner, D.D. and Zalutsky, M.R. Fluorine-18 labeled monoclonal antibody fragments: A potential approach for combining radioimmunotherapy and positron emission tomography. J. Nucl. Med. 33: 1535-1541, 1992.
  120. G Vaidyanathan, M Jay, RK Bera, PR Mayer, RK Brazzell, Scintigraphic evaluation of the ocular disposition of 18F-imirestat in rabbits., Pharmaceutical research, UNITED STATES, vol. 7 no. 11 (November, 1990), pp. 1198-200, ISSN 0724-8741
  121. G Vaidyanathan, MR Zalutsky, TR DeGrado, Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: application to m-iodobenzylguanidine., Bioconjugate chemistry, UNITED STATES, vol. 9 no. 6 , pp. 758-64, ISSN 1043-1802  [abs]
  122. G Vaidyanathan, DJ Affleck, MR Zalutsky, Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate., Bioconjugate chemistry, UNITED STATES, vol. 8 no. 5 , pp. 724-9, ISSN 1043-1802  [abs]
  123. G Vaidyanathan, DJ Affleck, MR Zalutsky, No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine., Bioconjugate chemistry, UNITED STATES, vol. 7 no. 1 , pp. 102-7, ISSN 1043-1802  [abs]
  124. G Vaidyanathan, MR Zalutsky, Improved synthesis of N-succinimidyl 4-[18F]fluorobenzoate and its application to the labeling of a monoclonal antibody fragment., Bioconjugate chemistry, UNITED STATES, vol. 5 no. 4 , pp. 352-6, ISSN 1043-1802  [abs]
  125. G Vaidyanathan, DJ Affleck, MR Zalutsky, Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate., Bioconjugate chemistry, UNITED STATES, vol. 4 no. 1 , pp. 78-84, ISSN 1043-1802  [abs]
  126. G Vaidyanathan, MR Zalutsky, 1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation., Bioconjugate chemistry, UNITED STATES, vol. 3 no. 6 , pp. 499-503, ISSN 1043-1802  [abs]
  127. G Vaidyanathan, MR Zalutsky, Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates., Bioconjugate chemistry, UNITED STATES, vol. 1 no. 6 , pp. 387-93, ISSN 1043-1802  [abs]
  128. G Vaidyanathan, MR Zalutsky, Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents., Bioconjugate chemistry, UNITED STATES, vol. 1 no. 4 , pp. 269-73, ISSN 1043-1802  [abs]

Duke University * Pratt * Reload * Login